InvestmentPitch Media Video Discusses FSD Pharma's Receipt of No Objection Letter from Health Canada for Clinical Trials for LUCID-21-302 for MS

Stock Information for FSD Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.